Skip to main content
Passa alla visualizzazione normale.

RICCARDO BONSIGNORE

Identifying and validating the presence of guanine-quadruplexes (G4) within the blood fluke parasite schistosoma mansoni

  • Authors: Craven H.M.; Bonsignore R.; Lenis V.; Santi N.; Berrar D.; Swain M.; Whiteland H.; Casini A.; Hoffmann K.F.
  • Publication year: 2021
  • Type: Articolo in rivista
  • Key words: Animals; Circular Dichroism; Female; Genome, Helminth; Male; Mice; Schistosoma mansoni; Signal Transduction; G-Quadruplexes
  • OA Link: http://hdl.handle.net/10447/533063

Abstract

Schistosomiasis is a neglected tropical disease that currently affects over 250 million individ-uals worldwide. In the absence of an immunoprophylactic vaccine and the recognition that mono-chemotherapeutic control of schistosomiasis by praziquantel has limitations, new strategies for managing disease burden are urgently needed. A better understanding of schistosome biology could identify previously undocumented areas suitable for the development of novel interventions. Here, for the first time, we detail the presence of G-quadru-plexes (G4) and putative quadruplex forming sequences (PQS) within the Schistosoma mansoni genome. We find that G4 are present in both intragenic and intergenic regions of the seven autosomes as well as the sex-defining allosome pair. Amongst intragenic regions, G4 are particularly enriched in 3´ UTR regions. Gene Ontology (GO) term analysis evi-denced significant G4 enrichment in the wnt signalling pathway (p<0.05) and PQS oligonu-cleotides synthetically derived from wnt-related genes resolve into parallel and anti-parallel G4 motifs as elucidated by circular dichroism (CD) spectroscopy. Finally, utilising a single chain anti-G4 antibody called BG4, we confirm the in situ presence of G4 within both adult female and male worm nuclei. These results collectively suggest that G4-targeted compounds could be tested as novel anthelmintic agents and highlights the possibility that G4-stabilizing molecules could be progressed as candidates for the treatment of schistosomiasis.